Repensar teleológicamente la persona: un estudio desde la filosofía de Robert Spaemann
Quién. Revista de filosofía personalista · 2019
DOI: 10.69873/aep.i10.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Quién. Revista de filosofía personalista, 2019. Verfasst von Peter Agulló. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The article aims to explain Robert Spaemann's concept of the person, a concept that cannot be separated from the teleological conception of nature. Thanks to teleology, the dualism in which philosophical anthropology had been stuck since Modernity will be overcome: if nature is teleological, there is continuity between nature and reason and not opposition, as the moderns thought. In this sense, human reason allows the transcendence of nature by recognizing existences outside of itself, which has traditionally been called benevolent love. This is a fundamental phenomenon that allows us to understand the value of the person and the specificity of personal relationships. On the other hand, based on the assumption that person is a normative term and, therefore, not descriptive, Spaemann extends personal status to every man. He thus opposes thinkers who reduce personality to those who manifest rationality and consciousness. From this point of view raised here, the value of the person is infinitely magnified and we can speak of dignity.
Zitieren
APA
Agulló, P. (2019). Repensar teleológicamente la persona: un estudio desde la filosofía de Robert Spaemann. Quién. Revista de filosofía personalista. https://doi.org/10.69873/aep.i10.125
Vancouver
Agulló P. Repensar teleológicamente la persona: un estudio desde la filosofía de Robert Spaemann. Quién. Revista de filosofía personalista. 2019. doi:10.69873/aep.i10.125
BibTeX
@article{Agull2019,
author = {Agulló, Peter},
title = {Repensar teleológicamente la persona: un estudio desde la filosofía de Robert Spaemann},
journal = {Quién. Revista de filosofía personalista},
year = {2019},
doi = {10.69873/aep.i10.125}
}
EUVIMED